Rebecca Berger, MD, a hospitalist in New York shares with me the dilemma of oncology patient handoffs as well as the physician-to-hospitalist relationship.
I don’t vividly recall interacting with hospitalists when I started training in 1995, but the hospitalists movement has taken off after the year 2000 and I wanted to discuss with Dr. Berger the impact of that on care of patients with cancer along with the challenges that hospitalists face when meeting patients for the first time; patients that they had no rapport with from previous outpatient care interactions.
This podcast is produced by the Journal of Clinical Pathways.
Dr. Simrit Parmar, founder of Cellenkos, joins the show to discuss her journey from the lab to the biotech startup world, detailing the inspiration behind launching her company, the challenges of securing funding, and the resilience required to overcome rejections. She shares insights into Cellenkos’ lead product, its progress toward market approval, and the rigorous
Carol Rausch—a healthcare professional, cancer researcher, and former patient with lymphoma—shares how her journey from researcher to patient transformed her understanding of medical language. She discusses the impact of word choice on patients, why certain battle and war metaphors can be harmful, and how language used in clinical settings differs from what resonates with those
Drs. David Braun and Toni Choueiri join to discuss a groundbreaking Nature study on a personalized neoantigen vaccine for adjuvant renal cell carcinoma. They explore the inspiration behind the trial, how the vaccine was developed and administered, and its safety profile. The conversation also covers patient outcomes after 3-4 years, including immune responses and disease
